The next board meeting for Foghorn Therapeutics Inc is on 13 Mar 2026 for the purpose of Foghorn Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Foghorn Therapeutics Inc has a share price target of US$ 11, revenue growth forecast of 38.1%, and profit growth estimate of 22.3% for FY25, based on top 10 analyst calls.